By: Christine Daya, Nicholas Klein, Sarah E. Kahn, Karla Cure, Matthew Larson
On October 20, 2022, the US Department of the Treasury released the Committee on Foreign Investment in the United
Continue Reading Guest Blog: New CFIUS Enforcement and Penalty Guidelines signal increased focus on enforcement
The DLA Piper Life Sciences sector team are delighted to announce the launch of our new Cross-border Guide to Clinical Trials and Privacy.
This Guide – created by privacy professionals from our global Life
Continue Reading Privacy requirements for clinical trials: a cross-border guide
The Directors of the UK Office of Financial Sanctions Implementation (OFSI) and the US Office of Foreign Assets Control (OFAC), Giles Thomson and Andrea Gacki, have announced, via a joint press statement1, the
Continue Reading Enhancing the US-UK Sanctions Partnership
Even before the pandemic, businesses have been facing new challenges in disputes – not just the extent of disputes, but their very nature.
DLA Piper’s first annual Product Liability Symposium, hosted by our Product Liability Diversity
Continue Reading Fortifying ourselves for 2023: Six key takeaways from DLA Piper’s D&I Product Liability Symposium
For the latest DLA Piper report on hydrogen, we partnered with Reuters to cover the conclusions of the Reuters Hydrogen 2022 conference. Clean hydrogen is widely regarded as a key component in achieving a sustainable
Continue Reading Report: Hydrogen 2022 – Tracking progress towards a clean hydrogen economy
In a recent speech, Deputy Attorney General (DAG) Lisa Monaco unveiled the Department of Justice’s top priorities for corporate criminal enforcement. The speech corresponded with the release of a memorandum (which has popularly been dubbed
Continue Reading Aligning your compliance program with the new DOJ guidance on corporate criminal enforcement: 3 takeaways and 4 practical steps
President Joe Biden has issued an Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy (EO) that will likely have impacts on the pharmaceutical, energy, agriculture, and engineering
Continue Reading Bioeconomy Executive Order: A whole-of-government approach to advancing biotechnology and biomanufacturingLatin American companies are increasingly leveraging innovative tech – and this changing digital landscape has important tax implications. Our latest panorama takes a look. Click here to read more.
Continue Reading Tax and digital transformation in Latin America
By: Roberto Vianna do R. Barros | Lucas Chimenti Serrano Bernabé
The importance of fintechs – neobanks and digital wallets – across Latin America is rising. Recent research by Bank of America demonstrates that, in
Continue Reading Digital Banking is Booming Across Latin America, Disrupting the Sector and Enhancing Service Delivery
The Federal Trade Commission is seeking public feedback on a proposed rulemaking to limit “commercial surveillance” by businesses that collect, sell, or share consumer information. The anticipated rules could potentially give the FTC the authority to
Continue Reading FTC explores sweeping new rules on data privacy and protection
